|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73.30 USD | +0.52% |
|
-0.66% | -6.18% |
| 02-02 | Susquehanna Downgrades Kaspi.kz to Neutral From Positive, Adjusts Price Target to $87 From $130 | MT |
| 11-28 | Kaspi.kz Moves Expected Closing of Rabobank Turkey Acquisition to Mid-2026 | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 152B | 316B | 494B | 773B | 1,122B | |||||
Finance Div. Revenues | 455B | 566B | 745B | 1,027B | 1,282B | |||||
Gain (Loss) on Sale of Investment, Total (Rev) | - | - | - | - | - | |||||
Interest And Invest. Income (Rev) | 32.58B | 50.64B | 74.17B | 110B | 127B | |||||
Other Revenues, Total | 2.78B | -47.45B | -42.24B | -6.66B | 13.2B | |||||
Total Revenues | 641B | 885B | 1,271B | 1,903B | 2,544B | |||||
Cost of Goods Sold, Total | 60.31B | 73.37B | 105B | 194B | 332B | |||||
Gross Profit | 581B | 811B | 1,166B | 1,709B | 2,212B | |||||
Selling General & Admin Expenses, Total | 67.5B | 34.03B | 50.39B | 51.36B | 83.92B | |||||
R&D Expenses | 29.18B | 42.75B | 60.12B | 88.66B | 104B | |||||
Other Operating Expenses | 27.62B | 34.38B | 55.21B | 79.63B | 114B | |||||
Other Operating Expenses, Total | 124B | 111B | 166B | 220B | 302B | |||||
Operating Income | 457B | 700B | 1T | 1,489B | 1,910B | |||||
Interest Expense, Total | -139B | -171B | -279B | -478B | -616B | |||||
Net Interest Expenses | -139B | -171B | -279B | -478B | -616B | |||||
Currency Exchange Gains (Loss) | - | - | - | 10.89B | -11.98B | |||||
EBT, Excl. Unusual Items | 318B | 529B | 721B | 1,022B | 1,282B | |||||
Asset Writedown | - | - | - | - | - | |||||
Other Unusual Items | - | - | -690M | - | - | |||||
EBT, Incl. Unusual Items | 318B | 529B | 721B | 1,022B | 1,282B | |||||
Income Tax Expense | 54.48B | 93.59B | 132B | 173B | 225B | |||||
Earnings From Continuing Operations | 263B | 435B | 589B | 849B | 1,057B | |||||
Net Income to Company | 263B | 435B | 589B | 849B | 1,057B | |||||
Minority Interest | -2.38B | -3.3B | -3.82B | -7.42B | -17.1B | |||||
Net Income - (IS) | 261B | 432B | 585B | 841B | 1,040B | |||||
Net Income to Common Incl Extra Items | 261B | 432B | 585B | 841B | 1,040B | |||||
Net Income to Common Excl. Extra Items | 261B | 432B | 585B | 841B | 1,040B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 1.36K | 2.25K | 3.05K | 4.43K | 5.48K | |||||
Basic EPS - Continuing Operations | 1.36K | 2.25K | 3.05K | 4.43K | 5.48K | |||||
Basic Weighted Average Shares Outstanding | 192M | 192M | 192M | 190M | 190M | |||||
Net EPS - Diluted | 1.35K | 2.22K | 3.02K | 4.38K | 5.43K | |||||
Diluted EPS - Continuing Operations | 1.35K | 2.22K | 3.02K | 4.38K | 5.43K | |||||
Diluted Weighted Average Shares Outstanding | 194M | 194M | 194M | 192M | 191M | |||||
Normalized Basic EPS | 1.02K | 1.7K | 2.33K | 3.33K | 4.13K | |||||
Normalized Diluted EPS | 1.01K | 1.68K | 2.3K | 3.29K | 4.1K | |||||
Dividend Per Share | 1.4K | 883 | 1.7K | 3.2K | 2.55K | |||||
Payout Ratio | 67.2 | 78.8 | 35.91 | 66.58 | 62.14 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 466B | 713B | 1,017B | 1,515B | 1,939B | |||||
EBITA | 459B | 705B | 1,004B | 1,494B | 1,915B | |||||
EBIT | 457B | 700B | 1T | 1,489B | 1,910B | |||||
EBITDAR | 471B | 718B | - | - | 1,947B | |||||
Total Revenues (As Reported) | 641B | 885B | 1,271B | 1,913B | 2,532B | |||||
Effective Tax Rate - (Ratio) | 17.14 | 17.7 | 18.28 | 16.95 | 17.58 | |||||
Total Current Taxes | 54.46B | 93.44B | 131B | 174B | 223B | |||||
Total Deferred Taxes | 11M | 148M | 738M | -962M | 2.08B | |||||
Normalized Net Income | 196B | 327B | 447B | 631B | 784B | |||||
Interest on Long-Term Debt | - | - | - | - | - | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | - | - | - | - | - | |||||
Selling and Marketing Expenses | 45.76B | 8.7B | 25.62B | 21.89B | 43.83B | |||||
General and Administrative Expenses | 18.14B | 21.59B | 24.77B | 29.47B | 31.92B | |||||
Research And Development Expense From Footnotes | 30.82B | 44.39B | 60.81B | 88.66B | 110B | |||||
Net Rental Expense, Total | 4.9B | 4.82B | - | - | 8.17B | |||||
Imputed Operating Lease Interest Expense | 24.96B | 26.41B | - | - | 269B | |||||
Imputed Operating Lease Depreciation | -20.06B | -21.59B | - | - | -261B | |||||
Stock-Based Comp., COGS (Total) | 397M | 1.15B | 1.67B | 1.75B | 1.34B | |||||
Stock-Based Comp., R&D Exp. (Total) | 4.82B | 9.02B | 9.14B | 10.41B | 10.07B | |||||
Stock-Based Comp., S&M Exp. (Total) | - | 27M | 653M | 686M | 542M | |||||
Stock-Based Comp., G&A Exp. (Total) | 6.3B | 9.86B | 8.52B | 8.02B | 5.01B | |||||
Total Stock-Based Compensation | 11.52B | 20.06B | 19.98B | 20.86B | 16.96B |
- Stock Market
- Equities
- KSPI Stock
- Financials Kaspi Bank
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















